AU5221998A - Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors - Google Patents

Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors

Info

Publication number
AU5221998A
AU5221998A AU52219/98A AU5221998A AU5221998A AU 5221998 A AU5221998 A AU 5221998A AU 52219/98 A AU52219/98 A AU 52219/98A AU 5221998 A AU5221998 A AU 5221998A AU 5221998 A AU5221998 A AU 5221998A
Authority
AU
Australia
Prior art keywords
interleukin
inhibitors
potionally
ketosteroids
combination therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52219/98A
Inventor
Patrick T. Prendergast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB1997/000414 external-priority patent/WO1997038695A1/en
Application filed by Individual filed Critical Individual
Publication of AU5221998A publication Critical patent/AU5221998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU52219/98A 1997-04-17 1997-10-16 Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors Abandoned AU5221998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
WO700414 1997-04-17
PCT/IB1997/000414 WO1997038695A1 (en) 1996-04-17 1997-04-17 Dhea combination therapy
PCT/EP1997/005716 WO1998047516A1 (en) 1997-04-17 1997-10-16 Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors

Publications (1)

Publication Number Publication Date
AU5221998A true AU5221998A (en) 1998-11-13

Family

ID=11004555

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52219/98A Abandoned AU5221998A (en) 1997-04-17 1997-10-16 Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors

Country Status (2)

Country Link
AU (1) AU5221998A (en)
WO (1) WO1998047516A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2352205A1 (en) * 1998-11-24 2000-06-08 Hollis-Eden Pharmaceuticals, Inc. Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis c virus and other togaviruses
JP2002531407A (en) * 1998-11-24 2002-09-24 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド Use of 17-ketosteroid compounds and their derivatives, metabolites and precursors in the treatment of malaria and in the treatment of African trypanosomiasis and American trypanosomiasis
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
WO2000032176A2 (en) * 1998-11-27 2000-06-08 Hollis-Eden Pharmaceuticals, Inc. Use of 17-ketosteroids for the treatment of toxoplasmosis and cryptosporidosis
WO2000035472A2 (en) * 1998-12-15 2000-06-22 Hollis-Eden Pharmaceuticals, Inc. Cytokine combination therapy
EP1444989A1 (en) 2003-02-07 2004-08-11 Giorgio Dr. Stassi Sensitizing cells for apoptosis by selectively blocking cytokines
US7589184B2 (en) 2004-05-24 2009-09-15 Genvault Corporation Stable protein storage and stable nucleic acid storage in recoverable form
US7553932B1 (en) 2005-04-25 2009-06-30 La Jolla Institute For Allergy And Immunology Methods of treating viral infection with IL-10 receptor antagonists
JP2012501681A (en) 2008-09-12 2012-01-26 ジェンボールト コーポレイション Matrix and media for storage and stabilization of biomolecules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3815472A1 (en) * 1988-05-06 1989-11-16 Centre Regional De Transfusion MONOCLONAL ANTICOERPER AND ITS USE
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
US5624823A (en) * 1991-11-22 1997-04-29 The General Hospital Corporation DNA encoding procine interleukin-10
JP3494647B2 (en) * 1992-08-20 2004-02-09 シェリング・コーポレーション Novel use of IL-4 and / or IL-10 and antibodies thereto
WO1994008589A1 (en) * 1992-10-09 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Treatment of systemic lupus erythematosus with dehydroepiandrosterone
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
WO1998047516A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
AU4787697A (en) Therapeutic gene
IL205765A0 (en) Mammalian cytokine: interleukin - b - 30 and isolated polunucleotides encoding the same
GB9720148D0 (en) Gene silencing materials and methods
EP0796628A3 (en) Inhaler
ZA973917B (en) Nasal dilator with areas of adhesive engagement of varying strength.
AU1820099A (en) Medical devices with improved properties
IL135742A0 (en) Progestin therapy with controlled bleeding
AU3737297A (en) Bacteriophage-mediated gene therapy
AU1616499A (en) Chemokine variants and methods of use
EP0907660A4 (en) Scarecrow gene, promoter and uses thereof
AU5289698A (en) Gas treatment devices
HU9800574D0 (en) Promoter of the cdc 25b gene, its preparation and use
AU5383498A (en) Human chemokine beta-13
AU6162198A (en) An altered telomere repeat binding factor and therapeutic use thereof
AU5221998A (en) Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors
AU3432397A (en) An alkylation catalyst and the application thereof
AU1769497A (en) Modified cytokines for therapeutic use
AU4373197A (en) Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof
AU5333298A (en) Compositions and methods for tumour therapy
AU5031398A (en) Gas treatment devices and systems
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU4209200A (en) Gas cooktop and control system
AU2677395A (en) Furnaces and lining
AU4571997A (en) Resin-coated segment, and manufacture thereof
AU3518695A (en) Gene therapy for transplantation and inflammatory or thrmbotic conditions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase